Oncology Clinical Trials in Hackensack, NJ

As of June 2026, 143 paid clinical trials are recruiting for Oncology in Hackensack, New Jersey. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

143 clinical trials for Oncology

·Clear filters·↓ Download CSV

Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy

for Carcinoma, Non-Small-Cell Lung

3 locations incl. Washington D.C.

Sponsor: Hackensack Meridian Health

Sex: All·Age: 18+

Code: NCT05715229·Phase 2·Recruiting

Apply to this trial

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

9 locations incl. Duarte

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT05981703·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

for Metastatic Breast Cancer

20 locations incl. Gilbert

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT05894239·Phase 3·Recruiting

Apply to this trial

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for Solid Tumors

11 locations incl. Los Angeles

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT05836324·Phase 1·Recruiting

Apply to this trial

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for Acute Myeloid Leukemia

Drug: Venetoclax

44 locations incl. Phoenix

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT05735184·Phase 1·Recruiting

Apply to this trial

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

for Metastatic Solid Tumors

4 locations incl. Chicago

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT05853367·Phase 1·Recruiting

Apply to this trial

Clinical Trial of Approaches to Prostate Cancer Surgery

for Prostate Cancer

9 locations incl. Duarte

Sponsor: Weill Medical College of Cornell University

Sex: Male·Age: 40 - 80

Code: NCT05155501·Recruiting

Apply to this trial

XTX301 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

11 locations incl. Sacramento

Sponsor: Xilio Development, Inc.

Sex: All·Age: 18+

Code: NCT05684965·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for Relapsed Non-Hodgkin Lymphoma

32 locations incl. Irvine

Sponsor: Lyell Immunopharma, Inc.

Sex: All·Age: 18+

Code: NCT05826535·Phase 1, Phase 2·Recruiting

Apply to this trial

Empathic Communication Skills (ECS) Training

for Lung Cancer

12 locations incl. Irvine

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18 - 100·Accepts healthy volunteers

Code: NCT05456841·Recruiting

Apply to this trial

Study of SGR-1505 in Mature B-Cell Neoplasms

for Mature B-Cell Neoplasm

16 locations incl. Gilbert

Sponsor: Schrödinger, Inc.

Sex: All·Age: 18+

Code: NCT05544019·Phase 1·Recruiting

Apply to this trial

Evaluating Novel Therapies in ctDNA Positive GI Cancers

for Colon Adenocarcinoma

3 locations incl. Washington D.C.

Sponsor: Georgetown University

Sex: All·Age: 18+

Code: NCT05482516·Phase 3·Recruiting

Apply to this trial

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for Solid Tumors

3 locations incl. Los Angeles

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT05471856·Phase 1·Recruiting

Apply to this trial

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

for Multiple Myeloma

13 locations incl. San Francisco

Sponsor: K36 Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05651932·Phase 1·Recruiting

Apply to this trial

A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

for HER2-positive Breast Cancer

14 locations incl. Los Angeles

Sponsor: Mersana Therapeutics

Sex: All·Age: 18+

Code: NCT05514717·Phase 1·Recruiting

Apply to this trial

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for Solid Tumor

9 locations incl. Newark

Sponsor: Sanofi

Sex: All·Age: 18+

Code: NCT05584670·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

for Carcinoma, Non-small-Cell Lung

Drug: Amivantamab

26 locations incl. La Jolla

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05498428·Phase 2·Recruiting

Apply to this trial

A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation

for AML

15 locations incl. Duarte

Sponsor: TScan Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05473910·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

5 locations incl. Birmingham

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT05372354·Phase 1, Phase 2·Recruiting

Apply to this trial

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

for Cervical Cancer

4 locations incl. Washington D.C.

Sponsor: Georgetown University

Sex: Female·Age: 18+

Code: NCT04865887·Phase 2·Recruiting

Apply to this trial

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

for Breast Cancer

10 locations incl. Miami

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05570253·Phase 2·Recruiting

Apply to this trial

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Drug: Venetoclax

45 locations incl. Phoenix

Sponsor: PedAL BCU, LLC

Sex: All·Age: 29 Days - 21

Code: NCT05183035·Phase 3·Recruiting

Apply to this trial

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

16 locations incl. Los Angeles

Sponsor: ModernaTX, Inc.

Sex: All·Age: 12+

Code: NCT05533697·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

for Follicular Lymphoma

Drug: Mosunetuzumab

9 locations incl. Washington D.C.

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05389293·Phase 2·Recruiting

Apply to this trial

Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma

for Multiple Myeloma

Drug: Iberdomide

2 locations incl. Washington D.C.

Sponsor: Hackensack Meridian Health

Sex: All·Age: 18+

Code: NCT05199311·Phase 1, Phase 2·Recruiting

Apply to this trial

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for Acute Lymphoblastic Leukemia

164 locations incl. Birmingham

Sponsor: PedAL BCU, LLC

Sex: All·Age: Up to 22

Code: NCT04726241·Phase 1, Phase 2·Recruiting

Apply to this trial

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

for Metastatic Malignant Neoplasm in the Lung

219 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT05235165·Phase 3·Recruiting

Apply to this trial

Long-Term Follow-up Study

for Lymphoma, Non-Hodgkin

31 locations incl. Birmingham

Sponsor: Caribou Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT05332054·Enrolling By Invitation

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

for Multiple Myeloma

28 locations incl. Phoenix

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05201781·Phase 4·Recruiting

Apply to this trial

Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

for Solid Tumor

4 locations incl. Hackensack

Sponsor: Impact Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05269316·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

for Advanced Solid Tumors

Drug: Calderasib

6 locations incl. Tampa

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT05067283·Phase 1·Recruiting

Apply to this trial

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

for Renal Cell Carcinoma (RCC)

46 locations incl. Phoenix

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05176483·Phase 1·Recruiting

Apply to this trial

First in Human, Dose Escalation Study of AN4005

for Advanced Solid Tumor

4 locations incl. Hackensack

Sponsor: Adlai Nortye Biopharma Co., Ltd.

Sex: All·Age: 18+

Code: NCT04999384·Phase 1·Recruiting

Apply to this trial

RAPA-201 Therapy of Solid Tumors

for Solid Tumor

1 location in Hackensack

Sponsor: Rapa Therapeutics LLC

Sex: All·Age: 18+

Code: NCT05144698·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for Cervical Cancer

11 locations incl. Clovis

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT04895709·Phase 1, Phase 2·Recruiting

Apply to this trial

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for Hematologic Malignancies

Drug: Nemtabrutinib

11 locations incl. Springdale

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT04728893·Phase 2·Recruiting

Apply to this trial

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for Metastatic Clear Cell Renal Cell Carcinoma

387 locations incl. Birmingham

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT04510597·Phase 3·Recruiting

Apply to this trial

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for Biochemically Recurrent Prostate Carcinoma

Drug: Apalutamide

342 locations incl. Anchorage

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male·Age: 18+

Code: NCT04423211·Phase 3·Recruiting

Apply to this trial

Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

for Glioblastoma

14 locations incl. Birmingham

Sponsor: Sabine Mueller, MD, PhD

Sex: All·Age: 6 Months - 25

Code: NCT04323046·Phase 1·Recruiting

Apply to this trial

Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

for Neuroblastoma

25 locations incl. Birmingham

Sponsor: Giselle Sholler

Sex: All·Age: Up to 31

Code: NCT04301843·Phase 2·Recruiting

Apply to this trial

Conditions in Oncology (Hackensack, NJ)

Solid tumor· 31 Non-small cell lung cancer (NSCLC)· 12 Breast cancer· 11 Acute myeloid leukemia (AML)· 11 Prostate cancer· 9 Multiple myeloma· 9 Hematologic malignancy· 8 Pancreatic cancer· 7 Ovarian cancer· 7 Endometrial cancer· 6 Leukemia (other)· 6 Myelodysplastic syndromes (MDS)· 6 Non-Hodgkin lymphoma· 6 Diffuse large B-cell lymphoma (DLBCL)· 6 Neuroblastoma· 6 Lung cancer· 5 Head and neck cancer· 5 Colorectal cancer· 4 Gastric cancer· 4 Liver cancer· 4 Chronic lymphocytic leukemia (CLL)· 4 Small lymphocytic lymphoma· 4 Cancer (any)· 4 Metastatic breast cancer· 3 Metastatic prostate cancer· 3 Bladder cancer· 3 Follicular lymphoma· 3 Osteosarcoma· 3 Triple-negative breast cancer· 2 Small cell lung cancer· 2 Esophageal cancer· 2 Biliary tract cancer· 2 Cervical cancer· 2 Fallopian tube cancer· 2 Glioblastoma· 2 Chronic myelomonocytic leukemia· 2 Acute lymphoblastic leukemia· 2 Myelofibrosis· 2 Mantle cell lymphoma· 2 Melanoma· 2 HER2-positive breast cancer· 1 Gastroesophageal junction cancer· 1 Kidney cancer· 1 Glioma· 1 Brain cancer· 1 Myeloproliferative neoplasm· 1 Hodgkin lymphoma· 1 Burkitt lymphoma· 1 Ewing sarcoma· 1 Rhabdomyosarcoma· 1